Relevant to the brain, MRP8 has also been previously implicated in neurological outcomes, such as depression [68], inflammation in the CNS [86,112,113,114,115], and elsewhere [72,116,117,118,119], as a mediator and biomarker. This evidence concerns the gene S100A8 and depressive symptom measurement.